Asthma Therapeutics Market, By Drug Class, By Route of Administration, By Distribution Channel, By Geography

Description

Asthma Therapeutics Market is estimated to be valued at USD 20.44 Bn in 2026 and is expected to reach USD 23.30 Bn by 2033, growing at a compound annual growth rate (CAGR) of 1.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 20.44 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	1.90%	2033 Value Projection:	USD 23.30 Bn

Asthma is a long-term inflammatory disease that causes inflammation and narrowing of the airways in the lung. It is characterized by various symptoms such as swelling or inflammation in the airways linings, coughing, shortness of breath, and tightness of chest. Asthma is classified into many different types including allergic asthma, non-allergic asthma, adult onset asthma, exercised induced asthma (that occurs with physical exertion), nocturnal asthma, and occupational asthma. Nocturnal is also known as the nighttime asthma. It is very serious type of asthma therefore, it needs a proper diagnosis and treatment.

Market Dynamics

Increasing launches of nebulizer by key players is expected to propel global asthma therapeutics market growth. For instance, in October 2018, Koninklijke Philips N.V. announced launch of its new mesh nebulizer, InnoSpire Go, in North America. This is used for the treatment of respiratory diseases including asthma. It is portable, hand-held nebulizer system, which is short time treatment. It delivers the medicine in just four minutes. InnoSpire Go designed for both adults and children.

However, product recall is major restraining factor for asthma therapeutics market growth, which is expected to hamper the market growth. For instance, in August 2018, Camber Pharmaceuticals were issued product recall alert from U.S. Food and Drug Administration for its Montelukast Sodium Tablets. These tablets are recalled because Montelukast Sodium Tablet bottles contain wrong medicine (Losartan Potassium Tablet).

Key features of the study

This report provides in-depth analysis of the global asthma therapeutics market size (USD Bn), and compound annual growth rate (CAGR (%)) for the forecast period: 2026 - 2033, considering 2025, as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global asthma therapeutics market based on the following parameters-company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include, GlaxoSmithKline Plc., Philips Healthcare, AstraZeneca Plc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Sanofi-Aventis SA, CareFusion Corporation, Sunovion Pharmaceuticals, Inc. Merck & Co., Inc., and Roche Diagnostics.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global asthma therapeutics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for global asthma therapeutics market, research and consulting firms, new entrants, and financial analysts

Market Segmentation

Drug Class Insights (Revenue, USD Bn, 2026 - 2033)
- Corticosteroids
- Beta2-Agonists (Long-Acting and Short-Acting)
- Leukotriene Inhibitors
- Long-Acting Muscarinic Antagonists (LAMA)
- Interleukin Antagonists
- Anti-Immunoglobulin E (IgE) Agents
- Combination Products
- Others
Route of Administration Insights (Revenue, USD Bn, 2026 - 2033)
- Oral, Inhalation
- Injection
Distribution Channel Insights (Revenue, USD Bn, 2026 - 2033)
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Bn, 2026 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- GlaxoSmithKline Plc.
- Philips Healthcare
- AstraZeneca Plc.
- Teva Pharmaceutical Industries Ltd.
- Boehringer Ingelheim GmbH,
- Sanofi-Aventis SA
- CareFusion Corporation
- Sunovion Pharmaceuticals, Inc.
- Merck & Co., Inc.
- Roche Diagnostics

Product Code: CMI2698

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Technology Advancements
Epidemiology
Product Recalls
Government Initiatives
Historical Overview
Merger and Acquisition
Regulatory and Reimbursement Scenario
PORTER'S Five Forces
PEST Analysis

4. Global Asthma Therapeutics Market, By Drug Class, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Corticosteroids
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Beta2-Agonists (Long-Acting and Short-Acting)
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Leukotriene Inhibitors
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Long-Acting Muscarinic Antagonists (LAMA)
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Interleukin Antagonists
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Anti-Immunoglobulin E (IgE) Agents
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Combination Products
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Others
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

5. Global Asthma Therapeutics Market, By Route of Administration, 2026-2033, (USD Bn)

Oral
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Inhalation
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Injection
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

6. Global Asthma Therapeutics Market, By Distribution Chanel, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospitals Pharmacies
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Retail Pharmacies
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Online Pharmacies
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

7. Global Asthma Therapeutics Market, By Region, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
North America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast By Country, 2026-2033, (USD Bn)
  - US.
  - Canada
Europe
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast By Country, 2026-2033, (USD Bn)
  - UK.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast By Country, 2026-2033, (USD Bn)
  - China
  - Japan
  - India
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast By Country, 2026-2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Africa
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast By Country, 2026-2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa
Middle East
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
- Market Size and Forecast By Country, 2026-2033, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East

8. Competitive Landscape

Heat Map Analysis
Company Profiles
- GlaxoSmithKline Plc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Philips Healthcare
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- AstraZeneca Plc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Teva Pharmaceutical Industries Ltd.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Boehringer Ingelheim GmbH
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Sanofi- Aventis SA
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- CareFusion Corporation
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Sunovion Pharmaceutical Ltd.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Merck & Co. Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Roche Diagnostics
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
  - Analyst Views

9. Section

References
Research Methodology
About us and Sales Contact